Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for thefourth quarter and fiscal year 2025. https://mma.prnewswire.com/media/2561044/Dolby_Logo.jpg “We finished FY25 strong, growing Dolby Atmos, Dolby Vision and imaging patents, and expanding our addressable market with momentum in Dolby OptiView and the introduction of a new imaging patent pool for content streamers,” said Kevin Yeaman, […]

Jazz Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in Citi's 2025 Global Healthcare Conference. Company management will participate in a fireside chat on Tuesday, December 2, 2025, at 6:45 a.m. PST / 9:45 a.m. EST / 2:45 p.m. GMT. An audio webcast of the fireside chat will be available via the

DuPont Announces Early Results of Tender Offer for Senior Notes

DuPont (NYSE: DD) announced today the early results of its previously announced tender offer (the “Tender Offer”) to purchase for cash up to $739,256,000 aggregate principal amount (the “Maximum Tender Amount”) of its 5.419% Notes due 2048 issued on November 28, 2018 (the “2048 Notes”). The Tender Offer is being made pursuant to the terms

BROOKDALE ANNOUNCES CHIEF OPERATING OFFICER

Tenured Leader Brings 40 Years of Senior Living Experience to Operations Brookdale Senior Living Inc. (NYSE: BKD) (“Brookdale” or the “Company”) is announcing that Mary Sue Patchett, current Interim Executive Vice President – Community and Field Operations, has been named Chief Operating Officer effective December 1st. Ms. Patchett brings 40 years of senior living operations

Jacobs Appoints Global Technology Leader Diane Bryant to Board of Directors

Jacobs (NYSE: J) today announced the appointment of Diane Bryant to its Board of Directors, effective immediately. Bryant is a distinguished technology executive with more than three decades of leadership experience spanning the global semiconductor industry, cloud computing services, artificial intelligence applications and technology-based healthcare solutions. Bryant is widely recognized as a transformative leader in

B. Riley Financial Reports First Quarter 2025 Results

B. Riley Financial, Inc. (NASDAQ: RILY) (“BRF” or the “Company”), a diversified holding company, today announced the filing of its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2025. Bryant Riley, Chairman and Co-Chief Executive Officer of B. Riley Financial, commented: “Our first quarter 2025 Form 10-Q filing marks an important

Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy

Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxalisib with pembrolizumab (Keytruda®) and standard chemotherapy has achieved an initial immune-complete response (iCR) per iRECIST criteria. This outcome suggests a profound radiologic response

Decision Notice – CIRO Sanctions Thomas Leonard Keough

On November 5, 2025, a hearing panel of the Canadian Investment Regulatory Organization (CIRO) held a hearing pursuant to the Mutual Fund Dealer Rules and accepted a settlement agreement, with sanctions, between Enforcement Staff and Thomas Leonard Keough. ThomasKeoughadmitted to failing to identify, report to the Dealer Member, or address in the best interests of

Chemung Financial Corporation Announces Quarterly Dividend

(NASDAQ:CHMG), ELMIRA, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) — Chemung Financial Corporation (Nasdaq: CHMG) announced today that its Board of Directors has approved a quarterly cash dividend of $0.34 per share, payable on January 2, 2026, to common stock shareholders of record as of the close of business on December 19, 2025. Chemung Financial Corporation

Scroll to Top